Ex-AstraZeneca boss David Brennan waives right to bonus
Monday 16 July 2012
The former boss of pharmaceuticals giant AstraZeneca has waived his entitlement to a 2012 annual bonus and has been denied performance-related share awards for the last two years, it emerged today.
Astra chief executive David Brennan stepped down in June after slashing full-year profit hopes and failing to tackle a shortage of blockbuster drugs as patents expire.
The FTSE 100 Index firm said Mr Brennan, who was with Astra for 36 years, will receive 11 months' salary worth £914,122 and will retain shares awarded in 2010 worth £1.5 million.
But he has waived any bonus entitlement for the portion of 2012 in which he worked for the group, while share awards made to Mr Brennan in 2011 and 2012 will be forfeited.
Mr Brennan has amassed a pension pot worth £14 million, according to the group's annual report, and could still receive further share awards from previous years.
He was one of a number of chief executives this year to succumb to shareholder pressure to step down, along with Aviva's Andrew Moss and Trinity Mirror's Sly Bailey.
Astra's shares fell around 6% between the time Mr Brennan took charge in 2006 and his departure last month.
The UK's second biggest drugs maker has struggled in recent months after it lost patent cover on antipsychotic drug Seroquel and tests on ovarian cancer drug Olaparib proved it to be ineffective.
Results for the first three months of the year blamed a "loss of exclusivity" for a 38% drop in pre-tax profits to 2.1 billion US dollars (£1.3 billion). The group subsequently lowered its target for full-year earnings per share.
Astra's so-called "patent cliff" - when revenues drop off as patents expire - is particularly steep as breast cancer drug Arimidex has already lost patent protection while acid reflux treatment Nexium and biggest seller Crestor will lose patent protection in the next four years.
- 1 Sofyen Belamouadden murder: The inside story of a crime that horrified Britain
- 3 Company breaks open Apple Watch to discover what it says is 'planned obsolescence'
Top 20 misconceptions people believe are true
Sofyen Belamouadden murder: The inside story of a crime that horrified Britain
'We're not heroes, just tourists': Swedish police officers on holiday stop vicious assault on New York subway
Nepal earthquake: More than 1,100 killed across four countries and in Mount Everest avalanche
Australian student Tommy Connolly, 23, adopts his pregnant, homeless 17-year-old cousin to give her a chance at 'a better life'
The sickening truth about food banks that the Tories don't want you to know
Katie Hopkins on LBC: Listen to caller taking The Sun columnist to task over migrant comments
Migrant boat disaster: Ukip candidate mocks victims in sickening Twitter post
Nigel Farage wants the BBC to stop making programmes like Doctor Who, Strictly Come Dancing, and Top Gear
Global warming: Scientists say temperatures could rise by 6C by 2100 and call for action ahead of UN meeting in Paris
General Election 2015: Britain would become a 'communist dictatorship' under Ed Miliband and Nicola Sturgeon, claims wife of Michael Gove
iJobs Money & Business
£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...
£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...
£22000 - £24000 per annum: Recruitment Genius: This is an opportunity to join ...